[Featured Stock] Min&Ji, Successful Business Diversification... Expectations for Stable Earnings Growth '↑'

[Asia Economy Reporter Hyunseok Yoo] Min&Ji is on the rise. It appears that securities firms' analysis, which expects stable performance growth due to successful business diversification, has influenced this trend.

As of 9:38 AM on the 31st, Min&Ji was trading at 16,900 KRW, up 1.20% (200 KRW) compared to the previous trading day.

Min&Ji's consolidated sales and operating profit for last year were 170.9 billion KRW and 28.2 billion KRW, respectively, representing increases of 38.1% and 4.6% compared to the previous year. Researcher Jongseon Park of Eugene Investment & Securities analyzed, "The significant increase in sales is due to an 8.7% rise in headquarters sales from services such as simple payment services and health guardian services, and a 17.8% growth in its subsidiary SettleBank." He added, "The sales of the subsidiary BioEleven were also reflected for the first time, driving the performance."

Eugene Investment & Securities forecasts that Min&Ji's sales and operating profit this year will reach 211.7 billion KRW and 34.9 billion KRW, respectively, marking increases of 23.8% and 23.7% year-on-year. He emphasized, "Continued growth in BioEleven's health functional food sales, the full-scale growth of SettleBank's simple cash payment service, and stable performance growth at the headquarters are expected."

This content was produced with the assistance of AI translation services.